We are live on
!
Find out more
SVGI
Sozo Ventures GP II Portfolio holdings
AUM
$1.33B
1-Year Est. Return
9.22%
This Fund
S&P 500
This Quarter
Est. Return
+51.39%
1 Year Est. Return
+9.22%
3 Year Est. Return
+8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$105M
(+56%)
Cap. Flow
+$6.69M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Metagenomi Therapeutics
MGX
|
+$6.69M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 97.91% |
| 2 | Healthcare | 2.09% |
Similar funds
SAM
SFI
4CM
P
SIMG
HT
WCWM
BA
Sozo Ventures GP II's Q1 2024 Portfolio in Review
As of Q1 2024, Sozo Ventures GP II held 2 positions worth $294M, up 56% from $189M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Sozo Ventures GP II's Q1 2024 filing shows 1 new position. Its largest new stake was Metagenomi Therapeutics: 581,577 shares worth $6.14M.
By sector, the portfolio is most concentrated in Financials at 98% of assets, down from 100% a quarter earlier, followed by Healthcare.
- Sozo Ventures GP II's largest Q1 2024 buy was Metagenomi Therapeutics: 581,577 shares worth $6.14M.
- Sozo Ventures GP II's ten largest holdings make up 100% of its $294M portfolio in Q1 2024.
- Sozo Ventures GP II opened 1 new position and closed 0 in Q1 2024.
- Sozo Ventures GP II's portfolio value rose 56% quarter-over-quarter to $294M.
Based on Sozo Ventures GP II's 13F filing for Q1 2024, filed 6 May 2024.